InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the complete record of transactions filed by Yea Christopher, Chief Development Officer. Officer active across 1 companies, notably KalVista Pharmaceuticals, Inc.. Cumulatively, 6 reports have been recorded. Total volume traded: €432k. The latest transaction was disclosed on 1 November 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€78,1615,000 shares@ €15.63220.0055% mcap47.5% of flow
Common Stock
SEC:0001209191-21-062730·
€78,1615,000 shares@ €15.63220.0055% mcap18.1% of flow
Common Stock
SEC:0001209191-21-062730:0·
€86,3845,000 shares@ €17.27690.0061% mcap52.5% of flow
Common Stock
SEC:0001209191-21-049800·
€86,3845,000 shares@ €17.27690.0061% mcap20.0% of flow
Common Stock
SEC:0001209191-21-049800:0·
5,000 shares
Common Stock
SEC:0001209191-21-030755·
€102,9715,000 shares@ €20.59430.0072% mcap23.8% of flow
Common Stock
SEC:0001209191-21-030755:0·
6 of 6 declarations
About Yea Christopher
Christopher Yea is the Chief Development Officer at KalVista Pharmaceuticals, Inc., a company focused on developing innovative treatments for rare diseases. In his role, Christopher is responsible for the business development strategy and market expansion opportunities for the company. His expertise in the pharmaceutical field contributes to KalVista's mission of improving patients' lives.
